... Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group. ; BLIJLEVENS, Nicole ; SCHWENKGLENKS ...

Jan 1, 2009 · ... high-dose chemotherapy, medical resource use, STEM-CELL TRANSPLANTATION, MARROW-TRANSPLANTATION, ECONOMIC OUTCOMES, RISK-FACTORS, BLOOD ...

melphalan or BEAM conditioning chemotherapy e European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;26:1519-1525. 63. Gertz ...

... patients receiving high-dose melphalan ... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

Oct 19, 2015 · ... receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J ...

... patients from a single center undergoing ... dose melphalan or BEAM conditioning chemotherapy–European Blood and Marrow Transplantation Mucositis Advisory Group.

... audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory ...

... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. N. BlijlevensM. Schwenkglenks +12 authors. S ...

... melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J. Clin. Oncol. 2008, 26, 1519–1525 ...

... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow ...